The Horizon Health web portal (www.horizonhealth.eu) has been officially launched today. The Horizon Health web portal aims to become a valuable online resource for journalists and interested citizens looking for accurate, up-to-date, and attractive information on health research funded by the EU
Antimicrobial resistance represents is a growing problem in public health due the increasing rarity of antibiotics capable of combating resistant bacteria. The COMBACTE project, that has just obtained 195 million euros worth of finance from the Innovative Medicines Initiative (IMI), aims to work to develop new antibiotics and introduce a successful clinical trials platform combining private and public research.
The HOMAGE (Heart OMics in AGEing) project, coordinated by the French National Institute of Health and Medical Research (INSERM), has been awarded a grant by the European Commission for a 6 year period. The project aims to identify and validate specific biomarkers of heart failure in order to prevent the development of the disease affecting elderly population. 17 research groups from 10 countries will collaborate to investigate new ways...
Comment la recherche sur le syndrome de Usher – handicap héréditaire particulièrement invalidant, portant atteinte aux deux sens majeurs, l’audition et la vision – a-t-elle franchi une étape majeure dans la compréhension des mécanismes à l’origine de la rétinopathie pigmentaire ? Comment est-elle parvenue à améliorer le diagnostic clinique et à développer le diagnostic moléculaire ? Comment prépare-t-elle les essais de thérapie génique de la rétinopathie du syndrome ?...
La Commission européenne a officiellement désigné le Human Brain Project (HBP) comme l’un de ses deux projets FET Flagship. Le HBP regroupera les scientifiques de tout le continent autour de l’un des plus grands défis de la science contemporaine: comprendre le cerveau humain.
The REBORNE project, funded by the European Commission and coordinated by Inserm, has just received the green light from the French Medicinal Agency ANSM to begin orthopaedic surgery clinical trials.
Why would our immune system turn against our own cells? This is the question that the combined Inserm/CNRS/ Pierre and Marie Curie University/Association Institut de Myologie have strived to answer in their “Therapies for diseases of striated muscle”, concentrating in particular on the auto-immune disease known as myasthenia gravis.
METACARDIS is a European project coordinated by Inserm
L’équipe de Behazine Combadière, Directrice de recherche Inserm au sein de l’Unité mixte de recherche 945 « Immunité et infection » (Inserm-Université Pierre et Marie Curie) à l’Hôpital Pitié-Salpêtrière, Paris, vient de montrer que la réponse immunitaire après vaccination par la voie intradermique déclenche la prolifération de cellules de l’immunité et la maturation de celles-ci dans un site jusque-là considéré comme un site de stockage des cellules « mémoires...
"Effective Perinatal Intensive Care in Europe: translating knowledge into evidence-based practice", is the theme that will bring together the 12 institutions taking part in the EPICE project - Effective Perinatal Intensive Care in Europe
The most recent studies on the connection between ischemic cardiovascular disease and job strain have been affected by many types of bias, such as the methodology used, the definition of stress and the number of cases studied. This has led to different risk values. To find out more, French researchers at Inserm and Université Versailles Saint Quentin joined a large European consortium called IPD-WORK Consortium, which brings together thirteen...
